Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring for oral anti-cancer drugs
NL-OMON21747Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jun 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial in cancer, sponsored by Netherlands Cancer Institute. Primary endpoint: Proportion below TDM target at third measurement. Started Jun 2017; status: recruiting.
02
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON21747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21747.